THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES
For citations:
THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES. Pediatric pharmacology. 2024;21(1):64. (In Russ.)
Views:
326
Email this article 